Tactile Systems Technology Inc
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as l… Read more
Tactile Systems Technology Inc (TCMD) - Net Assets
Latest net assets as of September 2025: $204.95 Million USD
Based on the latest financial reports, Tactile Systems Technology Inc (TCMD) has net assets worth $204.95 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($259.18 Million) and total liabilities ($54.23 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $204.95 Million |
| % of Total Assets | 79.08% |
| Annual Growth Rate | 23.0% |
| 5-Year Change | 73.62% |
| 10-Year Change | 694.04% |
| Growth Volatility | 33.22 |
Tactile Systems Technology Inc - Net Assets Trend (2013–2024)
This chart illustrates how Tactile Systems Technology Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Tactile Systems Technology Inc (2013–2024)
The table below shows the annual net assets of Tactile Systems Technology Inc from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $216.60 Million | +11.85% |
| 2023-12-31 | $193.64 Million | +59.51% |
| 2022-12-31 | $121.40 Million | -5.32% |
| 2021-12-31 | $128.23 Million | +2.79% |
| 2020-12-31 | $124.75 Million | +10.80% |
| 2019-12-31 | $112.59 Million | +26.13% |
| 2018-12-31 | $89.27 Million | +22.65% |
| 2017-12-31 | $72.79 Million | +22.05% |
| 2016-12-31 | $59.64 Million | +118.63% |
| 2015-12-31 | $27.28 Million | +10.64% |
| 2014-12-31 | $24.66 Million | +11.02% |
| 2013-12-31 | $22.21 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Tactile Systems Technology Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4479600000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $35.85 Million | 16.55% |
| Common Stock | $24.00K | 0.01% |
| Other Components | $180.72 Million | 83.44% |
| Total Equity | $216.60 Million | 100.00% |
Tactile Systems Technology Inc Competitors by Market Cap
The table below lists competitors of Tactile Systems Technology Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Yangling Metron New Material Co Ltd
SHE:300861
|
$543.71 Million |
|
SWAN CORP LTD
NSE:SWANCORP
|
$543.74 Million |
|
Suzhou Kingswood Printing Ink Co Ltd
SHE:300192
|
$544.02 Million |
|
ANTIN INFRASTR.PRT EO 1
F:8ZU
|
$544.18 Million |
|
OKEANIS ECO TANK. DL-001
F:7OK
|
$543.39 Million |
|
Molson Coors Canada Inc
TO:TPX-B
|
$543.33 Million |
|
Shaanxi Heimao Coking Co Ltd
SHG:601015
|
$543.21 Million |
|
Shenzhen Lihexing Co. Ltd.
SHE:301013
|
$543.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Tactile Systems Technology Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 193,642,000 to 216,597,000, a change of 22,955,000 (11.9%).
- Net income of 16,960,000 contributed positively to equity growth.
- Share repurchases of 3,508,000 reduced equity.
- Other factors increased equity by 9,503,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $16.96 Million | +7.83% |
| Share Repurchases | $3.51 Million | -1.62% |
| Other Changes | $9.50 Million | +4.39% |
| Total Change | $- | 11.85% |
Book Value vs Market Value Analysis
This analysis compares Tactile Systems Technology Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.05x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | $9.26 | $27.41 | x |
| 2014-12-31 | $1.85 | $27.41 | x |
| 2015-12-31 | $2.04 | $27.41 | x |
| 2016-12-31 | $3.54 | $27.41 | x |
| 2017-12-31 | $3.86 | $27.41 | x |
| 2018-12-31 | $4.61 | $27.41 | x |
| 2019-12-31 | $5.73 | $27.41 | x |
| 2020-12-31 | $6.45 | $27.41 | x |
| 2021-12-31 | $6.50 | $27.41 | x |
| 2022-12-31 | $6.05 | $27.41 | x |
| 2023-12-31 | $8.36 | $27.41 | x |
| 2024-12-31 | $8.97 | $27.41 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Tactile Systems Technology Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.83%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.79%
- • Asset Turnover: 0.98x
- • Equity Multiplier: 1.38x
- Recent ROE (7.83%) is above the historical average (4.66%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 14.21% | 8.49% | 1.27x | 1.32x | $935.30K |
| 2014 | 8.40% | 4.34% | 1.52x | 1.28x | $-395.50K |
| 2015 | 5.11% | 2.22% | 1.70x | 1.36x | $-1.33 Million |
| 2016 | 4.83% | 3.41% | 1.14x | 1.24x | $-3.08 Million |
| 2017 | 8.04% | 5.36% | 1.24x | 1.22x | $-1.42 Million |
| 2018 | 7.42% | 4.61% | 1.34x | 1.20x | $-2.30 Million |
| 2019 | 9.74% | 5.79% | 1.25x | 1.35x | $-288.50K |
| 2020 | -0.50% | -0.33% | 1.07x | 1.40x | $-13.10 Million |
| 2021 | -9.21% | -5.68% | 0.85x | 1.90x | $-24.63 Million |
| 2022 | -14.72% | -7.24% | 0.97x | 2.10x | $-30.01 Million |
| 2023 | 14.73% | 10.39% | 0.98x | 1.45x | $9.15 Million |
| 2024 | 7.83% | 5.79% | 0.98x | 1.38x | $-4.70 Million |
Industry Comparison
This section compares Tactile Systems Technology Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Tactile Systems Technology Inc (TCMD) | $204.95 Million | 14.21% | 0.26x | $543.43 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |